UBS Group’s Checkpoint Therapeutics CKPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-64,920
Closed -$262K 8951
2025
Q1
$262K Sell
64,920
-6,846
-10% -$27.7K ﹤0.01% 5124
2024
Q4
$230K Buy
71,766
+66,488
+1,260% +$213K ﹤0.01% 5180
2024
Q3
$11.8K Buy
5,278
+3,777
+252% +$8.46K ﹤0.01% 6452
2024
Q2
$3.23K Hold
1,501
﹤0.01% 7080
2024
Q1
$3.08K Sell
1,501
-23
-2% -$47 ﹤0.01% 6600
2023
Q4
$3.49K Sell
1,524
-88
-5% -$202 ﹤0.01% 6750
2023
Q3
$2.74K Sell
1,612
-1,140
-41% -$1.94K ﹤0.01% 6510
2023
Q2
$6.8K Buy
2,752
+1,252
+83% +$3.09K ﹤0.01% 6257
2023
Q1
$3.38K Sell
1,500
-2,303
-61% -$5.18K ﹤0.01% 7230
2022
Q4
$19.4K Buy
3,803
+731
+24% +$3.74K ﹤0.01% 6498
2022
Q3
$32K Buy
3,072
+903
+42% +$9.41K ﹤0.01% 5704
2022
Q2
$22K Buy
2,169
+319
+17% +$3.24K ﹤0.01% 5714
2022
Q1
$33K Sell
1,850
-630
-25% -$11.2K ﹤0.01% 5871
2021
Q4
$77K Sell
2,480
-1,129
-31% -$35.1K ﹤0.01% 5441
2021
Q3
$119K Buy
3,609
+234
+7% +$7.72K ﹤0.01% 4634
2021
Q2
$100K Sell
3,375
-1,458
-30% -$43.2K ﹤0.01% 4839
2021
Q1
$152K Buy
4,833
+3,813
+374% +$120K ﹤0.01% 4674
2020
Q4
$27K Buy
1,020
+993
+3,678% +$26.3K ﹤0.01% 5711
2020
Q3
$1K Sell
27
-1,690
-98% -$62.6K ﹤0.01% 6879
2020
Q2
$34K Sell
1,717
-1,461
-46% -$28.9K ﹤0.01% 5341
2020
Q1
$48K Buy
3,178
+137
+5% +$2.07K ﹤0.01% 4974
2019
Q4
$52K Buy
3,041
+1,154
+61% +$19.7K ﹤0.01% 5283
2019
Q3
$47K Buy
1,887
+1,471
+354% +$36.6K ﹤0.01% 5291
2019
Q2
$13K Buy
416
+332
+395% +$10.4K ﹤0.01% 6009
2019
Q1
$2K Buy
+84
New +$2K ﹤0.01% 6584
2018
Q2
Sell
-32
Closed -$1K 7025
2018
Q1
$1K Sell
32
-52
-62% -$1.63K ﹤0.01% 6726
2017
Q4
$3K Buy
84
+3
+4% +$107 ﹤0.01% 6544
2017
Q3
$7K Sell
81
-59
-42% -$5.1K ﹤0.01% 6138
2017
Q2
$14K Buy
+140
New +$14K ﹤0.01% 5591